The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.975
Bid: 0.95
Ask: 1.00
Change: -0.025 (-2.50%)
Spread: 0.05 (5.263%)
Open: 1.00
High: 1.00
Low: 0.975
Prev. Close: 1.00
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Global collaboration agreement with Axcend Corp

26 Feb 2020 07:00

RNS Number : 1206E
Microsaic Systems plc
26 February 2020
 

26 Feb 2020

Microsaic Systems plc

 

("Microsaic" or the "Company")

 

Global collaboration and commercialisation agreement with Axcend Corp

 

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, is pleased to announce that it has signed a global integration and joint sales and marketing heads of terms with Axcend Corp ("Axcend") to integrate the compact Microsaic 4500 MiD® MS with the portable Axcend Focus LC® ("LC/MS system"), and to commercialise the combined system globally using both companies' direct sales and selected distribution channels. Microsaic has a direct sales presence in the UK and certain European markets, while Axcend has a direct presence in North America; both partners have extensive and growing networks of international distribution partners.

 

The Microsaic 4500 MiD® is a robust and compact MS detector with an integrated computer and vacuum pump, whose small footprint and ease of use make it deployable anywhere within a laboratory or processing facility. The Axcend Focus LC® is a very small footprint, high-performance liquid chromatography system ("HPLC").

 

Both LC and MS are standard analyses that are widely adopted and the ability to offer both in an easy-to-use compact LC/MS system is expected to deliver users with significant efficiency benefits without compromising on performance, speed or reliability.

 

Liquid chromatography ("LC") is a well-established method of sample separation. LC very commonly uses MS as a detection method in a wide range of markets, such as chemicals, pharmaceuticals and environmental analysis. Typically, due in part to the size and complexity of traditional LC and MS systems, such analyses are performed in a centralised laboratory. The combination of Axcend and Microsaic's small footprint technologies supports timely testing in the location where samples are taken, as well as in centralised laboratories. In addition, the combined LC/MS system utilises substantially less solvents than the traditonal LC and MS systems, which can, therefore, result in lower running costs and solvent disposal.

The analytical HPLC-MS market is a $5 billion market today, according to Top Down Analytics, 2019 Outlook; Analytical Instruments Industry. 

Glen Mella, CEO, Axcend commented: "We have an award-winning, lightweight and powerful HPLC that is easy-to-use and cost-competitive, especially on an operational basis. Yet many scientists need the added benefit of an LC/MS system to produce greater analytical insights. We are confident that Microsaic will be an excellent partner for delivering compelling solutions to our customers."

Glenn Tracey, CEO, Microsaic added: "We are particularly excited by this partnership, which combines two highly differentiated compact products into a very powerful LC/MS system. In addition to the benefits for customers, this collaboration also leverages our shared resources of marketing, direct sales and distribution channels globally. As far as we are aware there is no other LC/MS combination today which provides such a powerful offering in such a small footprint."

 

Enquiries:

 

 

Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD

+44 (0) 1483 751 577

 

N+1 Singer (Nominated Adviser & Broker)

Aubrey Powell / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

 

+44 (0)20 7496 3000

IFC Advisory Ltd (Financial PR)

Graham Herring

Florence Chandler

+44 (0)20 3934 6630

 

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company is working with a range of established global life science OEM partners, distributors and research organisations to co-develop and commercialise new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

 

Microsaic's core products, the 4500 MiD®, and MiD®ProteinID are robust and compact MS systems, retaining the functionality of larger conventional MS systems, easier to use by non-specialists, consuming less energy and having lower running costs. For more information, please go to www.microsaic.com.

 

About Axcend

Based in Provo, Utah, Axcend is a provider of innovative, compact nano-flow, high-performance liquid chromatography (HPLC) systems. These systems allow scientists to Take the Lab to the Sample™ and deliver dramatic improvements in portability, ease-of-operation, and rapid and convenient deployment, as well as coupling to other analytical systems (such as mass spectrometers).

 

For more information please go to www.axcendcorp.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRFELLLBLLBBBV
Date   Source Headline
5th Mar 20197:00 amRNSMSYS jointly publishes bioprocessing data with MIT
19th Feb 20197:00 amRNSNotice of Results
11th Jan 20197:00 amRNSNew Protein Identification Product
19th Dec 201811:20 amRNSBioprocessing partnership update & trading update
7th Nov 20187:00 amRNSExclusive US and Canada Distribution Agreement
3rd Sep 20187:00 amRNSInterim Results
7th Aug 20187:00 amRNSNotice of Results
29th Jun 20184:12 pmRNSHolding(s) in Company
26th Jun 20182:04 pmRNSHolding(s) in Company
25th Jun 201810:10 amRNSDirectors' Interests
22nd Jun 201810:40 amRNSResult of GM, Completion of Fundraising & TVR
21st Jun 20187:00 amRNSDistribution Agreement with Amedis, spol. s ro.
13th Jun 20187:00 amRNSDistribution Agreement with Omicron Research Ltd.
6th Jun 20187:00 amRNSSuccessful Fundraising of £5.5 million
5th Jun 20184:46 pmRNSPrimaryBid.com Offer
5th Jun 20184:45 pmRNSFundraising
24th May 20187:00 amRNSDistribution Agreement with Stable Arm Sdn. Bhd.
9th May 20187:00 amRNSAgreement with Rightek Co., Ltd.
4th May 201811:25 amRNSResult of AGM
4th May 20187:00 amRNSAGM Statement
12th Apr 20187:00 amRNSMicrosaic signs Agreement with Knauer
6th Apr 20187:00 amRNSNotice of AGM and Posting of Annual Report
28th Mar 20187:00 amRNSAgreement with Unimicro Technologies Inc.
23rd Mar 20184:45 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSCommercial contract with CPI Innovation Services
5th Mar 20187:00 amRNSFinal Results
21st Feb 20187:00 amRNSNotice of Results
3rd Jan 20187:00 amRNSAward of Options
19th Dec 20177:00 amRNSDirectorate Change
13th Dec 20177:00 amRNSResearch agreement with global biopharma partner
28th Sep 20177:00 amRNSInterim Results
25th Sep 20177:00 amRNSAppointment of CEO
13th Sep 20177:00 amRNSMicrosaic to Exhibit at BioProcess International
14th Aug 20177:00 amRNSNotice of Results
19th Jun 20177:00 amRNSTrading Statement
15th May 201711:42 amRNSResult of AGM
11th May 20177:00 amRNSMicrosaic Enhances Bioprocessing Capabilities
26th Apr 20177:00 amRNSIntegration with SCPA chromatography software
21st Apr 20177:00 amRNSNotice of AGM
7th Apr 20177:00 amRNSAgreement
21st Mar 20177:00 amRNSFinal Results
13th Mar 20177:00 amRNSChange of registrar
24th Jan 201712:56 pmRNSAppointment of Interim Chairman
13th Dec 20167:00 amRNSTrading Statement
28th Sep 20167:00 amRNSDirectorate Change
21st Sep 20164:39 pmRNSHolding(s) in Company
16th Sep 20161:44 pmRNSDirector/PDMR Shareholding
15th Sep 20161:03 pmRNSHolding(s) in Company
15th Sep 201610:02 amRNSTR-1: Notification of Major Interest in Shares
14th Sep 20165:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.